People In The News: Topside Changes At Oxygen Biotherapeutics, EMD Serono And Volatarr; CMS’s Shrank Lands At CVS Caremark
Executive Summary
Oxygen Biotherapeutics names John Kelley CEO following acquisition of Phyxius Pharma; former director at CMS innovation center William Shrank named CSO, CMO at CVS Caremark; Paris Panayiotopoulos moves from president role at Merck Serono to same title at EMD Serono; more personnel announcements in this month’s column.
You may also be interested in...
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.
Observational Study Quality Checklist Gets Mixed Reviews In Validation Study
The validation study finds challenges in correlating expert opinion on what is a good observational study that can be used for decision making and what the GRACE Initiative checklist predicts is a good study. Validation study author Robert Dubois believes the checklist can be predictive of a good study when the context of how an observational study’s findings are to be used is clear.